Marinus Pharmaceuticals Inc. | Key People and Executives
Christopher Michael Cashman
Chairman, President & Chief Executive Officer
Scott N. Braunstein
Independent Director
Seth H. Z. Fischer
Independent Director
Tim M. Mayleben
Lead Independent Director
Michael R. Dougherty
Independent Director
Enrique J. Carrazana
Independent Director
Nicole Vitullo
Independent Director
Christopher Michael Cashman
Chairman, President & Chief Executive Officer
Edward F. Smith
Chief Financial Officer, Secretary, Treasurer & VP
Lorianne K. Masuoka
Chief Medical Officer
Jaakko Lappalainen
Vice President-Clinical Development
Lisa M. Caperelli
Executive Director-Investor & Strategic Relations
Scott N. Braunstein
Independent Director
Seth H. Z. Fischer
Independent Director
Tim M. Mayleben
Lead Independent Director
Michael R. Dougherty
Independent Director
Enrique J. Carrazana
Independent Director
Nicole Vitullo
Independent Director
Address |
170 North Radnor Chester Road Radnor Pennsylvania 19087 United States
|
Employees
|
- |
Website |
http://www.marinuspharma.com |
Updated |
07/08/2019 |
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the identification and development of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded by Geoffrey E. |